ATE213412T1 - 1h-4(5)substituierte imidazolderivate - Google Patents

1h-4(5)substituierte imidazolderivate

Info

Publication number: ATE213412T1
Authority: AT; Austria
Prior art keywords: ring structure; methyl; hydrogen; imidazole derivatives; taken together
Prior art date: 1995-05-30

Application number

AT96920543T

Other languages

English (en)

Inventor

James G Phillips

Clark E Tedford

Nishith C Chaturvedi

Original Assignee

Gliatech Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-05-30

Filing date

1996-05-29

Publication date

2002-03-15

1996-05-29 Application filed by Gliatech Inc filed Critical Gliatech Inc

2002-03-15 Application granted granted Critical

2002-03-15 Publication of ATE213412T1 publication Critical patent/ATE213412T1/de

Links

RAXXELZNTBOGNW-UHFFFAOYSA-N 1H-imidazole Chemical class C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 title 1
229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 title 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 6
125000002619 bicyclic group Chemical group 0.000 abstract 2
NNBZCPXTIHJBJL-UHFFFAOYSA-N decalin Chemical compound C1CCCC2CCCCC21 NNBZCPXTIHJBJL-UHFFFAOYSA-N 0.000 abstract 2
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 2
229910052739 hydrogen Inorganic materials 0.000 abstract 2
239000001257 hydrogen Substances 0.000 abstract 2
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
PDELQDSYLBLPQO-UHFFFAOYSA-N 2,3,3a,4,5,6,7,7a-octahydro-1h-indole Chemical group C1CCCC2NCCC21 PDELQDSYLBLPQO-UHFFFAOYSA-N 0.000 abstract 1
125000000217 alkyl group Chemical group 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
125000000753 cycloalkyl group Chemical group 0.000 abstract 1
125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 abstract 1
125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 abstract 1
125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/417—Imidazole-alkylamines, e.g. histamine, phentolamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C07D233/60—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Pulmonology (AREA)
Immunology (AREA)
Heart & Thoracic Surgery (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Cardiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Luminescent Compositions (AREA)
Liquid Crystal Substances (AREA)
Epoxy Resins (AREA)
Plural Heterocyclic Compounds (AREA)

AT96920543T 1995-05-30 1996-05-29 1h-4(5)substituierte imidazolderivate ATE213412T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US45452295A	1995-05-30	1995-05-30
PCT/US1996/007873 WO1996038142A1 (en)	1995-05-30	1996-05-29	1h-4(5)-substituted imidazole derivatives

Publications (1)

Publication Number	Publication Date
ATE213412T1 true ATE213412T1 (de)	2002-03-15

Family

ID=23804951

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT96920543T ATE213412T1 (de)	1995-05-30	1996-05-29	1h-4(5)substituierte imidazolderivate

Country Status (16)

Country	Link
US (1)	US6166060A (de)
EP (1)	EP0841922B1 (de)
JP (1)	JPH11506106A (de)
KR (1)	KR19990022136A (de)
CN (1)	CN1192144A (de)
AT (1)	ATE213412T1 (de)
AU (1)	AU721325B2 (de)
CA (1)	CA2222099A1 (de)
DE (1)	DE69619381T2 (de)
DK (1)	DK0841922T3 (de)
ES (1)	ES2170859T3 (de)
FI (1)	FI974364A0 (de)
NO (1)	NO975483D0 (de)
NZ (1)	NZ308931A (de)
PT (1)	PT841922E (de)
WO (1)	WO1996038142A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5932590A (en) *	1996-12-05	1999-08-03	Merck & Co., Inc.	Inhibitors of farnesyl-protein transferase
GB2344588B (en) *	1997-07-25	2001-11-14	Black James Foundation	1H-4(5)-substituted imidazole derivatives their preparation and their use as histamine H 3 receptor ligands
GB9715814D0 (en) *	1997-07-25	1997-10-01	Black James Foundation	Histamine H3 receptor ligands
WO2000042023A1 (en)	1999-01-18	2000-07-20	Novo Nordisk A/S	Substituted imidazoles, their preparation and use
US6908926B1 (en)	1999-04-16	2005-06-21	Novo Nordisk A/S	Substituted imidazoles, their preparation and use
US6610721B2 (en)	2000-03-17	2003-08-26	Novo Nordisk A/S	Imidazo heterocyclic compounds
US6437147B1 (en)	2000-03-17	2002-08-20	Novo Nordisk	Imidazole compounds
EP1313470A4 (de)	2000-08-17	2005-02-16	Gliatech Inc	Neue alicyclische imidazole as h 3 wirkstoffe
FR2827863A1 (fr) *	2001-07-27	2003-01-31	Sanofi Synthelabo	Derives d'aminoalkylimidazole, leur preparation et leur utilisation en therapeutique
AU2003248584A1 (en) *	2002-03-01	2003-09-16	Warner-Lambert Company Llc	Method of treating osteoarthritis
PL1620082T3 (pl) *	2003-05-05	2010-10-29	Probiodrug Ag	Medyczne zastosowanie inhibitorów cyklazy glutaminylowej i glutaminianowej do leczenia choroby Alzheimera i zespołu Downa
AU2004290499C1 (en) *	2003-11-03	2011-02-24	Probiodrug Ag	Combinations useful for the treatment of neuronal disorders
US7902191B2 (en)	2004-02-25	2011-03-08	Eli Lilly And Company	Histamine H3 receptor antagonists, preparation and therapeutic uses
CA2561628C (en)	2004-04-01	2012-05-08	Eli Lilly And Company	Histamine h3 receptor agents, preparation and therapeutic uses
CN1956952B (zh) *	2004-06-02	2013-12-11	伊莱利利公司	组胺h3受体药剂、制备和治疗学用途
GB0413605D0 (en) *	2004-06-17	2004-07-21	Addex Pharmaceuticals Sa	Novel compounds
EP1784400B1 (de)	2004-08-23	2015-01-14	Eli Lilly And Company	Histamin-h3-rezeptor-mittel, deren herstellung und therapeutische verwendung
WO2006044228A1 (en)	2004-10-18	2006-04-27	Eli Lilly And Company	Histamine h3 receptor inhibitors, preparation and therapeutic uses
WO2006058023A2 (en) *	2004-11-23	2006-06-01	Merck & Co., Inc.	Treatment of stroke with histamine h3 inverse agonists or histamine h3 antagonists
DE602006010833D1 (de) *	2005-03-17	2010-01-14	Lilly Co Eli	Pyrrolidinderivate als histamin-h3-rezeptorantagonisten
EP1707203A1 (de)	2005-04-01	2006-10-04	Bioprojet	Verwendung von Alkylaminen, die kein Imidazole enthalten, als Histamin H3 Rezeptor Liganden, zur Behandlung von Morbus Parkinson, obstruktiver Schlafapnoe, vaskularer Demenz, Demenz mit Lewy Korpen
CN101151244B (zh)	2005-04-01	2014-09-03	伊莱利利公司	组胺h3受体活性剂、制备和治疗用途
EP1717235A3 (de)	2005-04-29	2007-02-28	Bioprojet	Phenoxypropylpiperidine und -pyrrolidine und ihre Verwendung als Liganden für den Histamin H3-Rezeptor
EP1717233A1 (de)	2005-04-29	2006-11-02	Bioprojet	Liganden für den Histamin H3-Rezeptor und ihre therapeutische Anwendung
WO2007063385A2 (en) *	2005-12-01	2007-06-07	Pfizer Products Inc.	Spirocyclic amine histamine-3 receptor antagonists
US20100168197A1 (en) *	2007-02-28	2010-07-01	Naresh Kumar	Muscarinic receptor antagonists
WO2013151982A1 (en)	2012-04-03	2013-10-10	Arena Pharmaceuticals, Inc.	Methods and compounds useful in treating pruritus, and methods for identifying such compounds
AU2017325870B2 (en) *	2016-09-16	2021-07-22	Research Traingle Institute	Tetrahydroisoquinoline kappa opioid antagonists

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2069481B (en) *	1980-02-13	1983-07-27	Farmos Oy	Substituted imidazole derivatives
GB2110663B (en) *	1981-12-04	1985-08-07	Farmos Group Ltd	Imidazole derivatives
FR2579596B1 (fr) *	1985-03-26	1987-11-20	Inst Nat Sante Rech Med	(imidazolyl-4) piperidines, leur preparation et leur application en therapeutique
NL8601585A (nl) *	1986-06-19	1988-01-18	Vereniging Voor Christelijk Wetenschappelijk Onderwijs	N-(2-gesubstitueerde alkyl)-n-imidazol-4-yl alkyl guanidine.
US4996221A (en) *	1987-01-13	1991-02-26	The Board Of Trustees Of The Leland Stanford Junior University	Histamine derivatives as immune modulators
IL92441A (en) *	1988-12-07	1993-05-13	Tanabe Seiyaku Co	Imidazole containing peptides, their preparation and pharmaceutical compositions containing them
US5248689A (en) *	1989-11-06	1993-09-28	Smithkline Beecham Corporation	Substituted N-(imidazolyl)alkyl alanine derivatives
FR2669030B1 (fr) *	1990-11-14	1992-12-31	Adir	Nouveaux derives d'imidazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2671083B1 (fr) *	1990-12-31	1994-12-23	Inst Nat Sante Rech Med	Nouvelles 4-(4-imidazolyl) piperidines substituees en 1, leur preparation ainsi que leurs applications therapeutiques.
EP0573542B1 (de) *	1991-02-27	1997-10-15	Seed Capital Investments( Sci) B.V.	Imidazol-derivate mit antagonistischer aktivität auf den histamin-h3-receptor
FR2686084B1 (fr) *	1992-01-10	1995-12-22	Bioprojet Soc Civ	Nouveaux derives de l'imidazole, leur preparation et leurs applications therapeutiques.
US5217986A (en) *	1992-03-26	1993-06-08	Harbor Branch Oceanographic Institution, Inc.	Anti-allergy agent
FR2711990B1 (fr) *	1993-11-05	1995-12-08	Exsymol Sa	Produit pseudodipeptide possédant un groupement imidazole, et applications thérapeutiques, cosmétologiques et agroalimentaires.
FR2732017B1 (fr) *	1995-03-21	2000-09-22	Inst Nat Sante Rech Med	Nouveaux derives de l'imidazole antagonistes et/ou agonistes du recepteur h3 de l'histamine, leur preparation et leurs applications therapeutiques

1996
- 1996-05-29 CA CA002222099A patent/CA2222099A1/en not_active Abandoned
- 1996-05-29 EP EP96920543A patent/EP0841922B1/de not_active Expired - Lifetime
- 1996-05-29 ES ES96920543T patent/ES2170859T3/es not_active Expired - Lifetime
- 1996-05-29 KR KR1019970708615A patent/KR19990022136A/ko not_active Ceased
- 1996-05-29 JP JP8536607A patent/JPH11506106A/ja not_active Ceased
- 1996-05-29 PT PT96920543T patent/PT841922E/pt unknown
- 1996-05-29 NZ NZ308931A patent/NZ308931A/en unknown
- 1996-05-29 DK DK96920543T patent/DK0841922T3/da active
- 1996-05-29 CN CN96195926A patent/CN1192144A/zh active Pending
- 1996-05-29 AU AU58817/96A patent/AU721325B2/en not_active Ceased
- 1996-05-29 DE DE69619381T patent/DE69619381T2/de not_active Expired - Fee Related
- 1996-05-29 WO PCT/US1996/007873 patent/WO1996038142A1/en not_active Ceased
- 1996-05-29 AT AT96920543T patent/ATE213412T1/de not_active IP Right Cessation
1997
- 1997-10-10 US US08/948,801 patent/US6166060A/en not_active Expired - Fee Related
- 1997-11-28 NO NO975483A patent/NO975483D0/no unknown
- 1997-11-28 FI FI974364A patent/FI974364A0/fi not_active IP Right Cessation

Also Published As

Publication number	Publication date
DE69619381D1 (de)	2002-03-28
JPH11506106A (ja)	1999-06-02
CA2222099A1 (en)	1996-12-05
FI974364A7 (fi)	1997-11-28
DK0841922T3 (da)	2002-06-03
AU721325B2 (en)	2000-06-29
EP0841922A4 (de)	1999-03-10
EP0841922A1 (de)	1998-05-20
CN1192144A (zh)	1998-09-02
US6166060A (en)	2000-12-26
WO1996038142A1 (en)	1996-12-05
ES2170859T3 (es)	2002-08-16
DE69619381T2 (de)	2002-11-21
PT841922E (pt)	2002-07-31
EP0841922B1 (de)	2002-02-20
NO975483D0 (no)	1997-11-28
AU5881796A (en)	1996-12-18
MX9709210A (es)	1998-07-31
KR19990022136A (ko)	1999-03-25
FI974364A0 (fi)	1997-11-28
NZ308931A (en)	2001-10-26

Legal Events

Date	Code	Title	Description
2002-07-15	UEP	Publication of translation of european patent specification
2005-02-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
DE69619381D1 (de)	2002-03-28	1h-4(5)substituierte imidazolderivate
NO975484D0 (no)	1997-11-28	2-(1H-4(5)-imidazoyl)sykloprylderivater
GR3036017T3 (en)	2001-09-28	Heterocyclic fungicides
TW334418B (en)	1998-06-21	Stilbene derivatives and pharmaceutical compositions
EA199800051A1 (ru)	1998-08-27	Производные бензамида и их применение в качестве антагонистов вазопрессина
IT1283588B1 (it)	1998-04-22	Miscela sinergica di agenti stabilizzanti
DE3683823D1 (de)	1992-03-19	2-alkynyladenosine als aktive bestandteile enthaltende antihypertensive mittel.
CA2113229A1 (en)	1995-07-12	Anti-fibrotic quinazolinone-containing compositions and methods for the use thereof
ES2176204T3 (es)	2002-12-01	Antidepresivos que contienen un derivado de xantina.
HUP9802196A2 (hu)	1999-01-28	Szubsztituált ciano-fenil-uracil-származékok, előállításuk és alkalmazásuk, a vegyületeket hatóanyagként tartalmazó herbicid és inszekticid készítmények
EP0865281A4 (de)	1999-07-28	Naphthyl substituierte benzimidazolderivate als antikoagulantien
DK0759919T3 (da)	1999-07-26	Azolidindioner som antihyperglykæmiske midler
NZ503912A (en)	2002-09-27	Piperidinylaminomethyl trifluoromethyl cyclic ether compounds and their use as substance P antagonists
GB9408185D0 (en)	1994-06-15	New benzamide derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
CA2159817A1 (en)	1995-08-31	Pyrimidine Acyclonucleoside Derivatives
AR247744A1 (es)	1995-03-31	Compuestos organosilano y catalizadores que contienen dichos compuestos
FI850151A0 (fi)	1985-01-14	6,6-etylen-15,16-metylen-3-oxo-17 -pregn-4-en-21,17-karbolaktoner, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska preparat.
DE69530510D1 (de)	2003-05-28	Chinazolinon enthaltende arzneimittel und verfahren zu deren verwendung
ES2188282T3 (es)	2003-06-16	Compuestos de 3-(fenilo sustituido)-5-tienil-1,2,4-triazol con actividad contra la mosca blanca.
HUP9801133A2 (hu)	1998-08-28	1,2,4-Triazol-származékok, továbbá ilyen vegyületeket hatóanyagként tartalmazó fungicid készítmények
NO983527L (no)	1998-09-28	Dihydrobenzofuran og relaterte forbindelser anvendelig som anti-inflammatoriske midler
MY130190A (en)	2007-06-29	Method for the preparation of 4-halo-2'- nitrobutyrophenone compounds
JPS52100470A (en)	1977-08-23	Synthesis of hydantoin derivatives
ATE36520T1 (de)	1988-09-15	Polyprenylverbindung, ihre herstellung und pharmazeutische verwendung.
MX9702486A (es)	1998-04-30	La fabricacion de levobupivacaina y sus analogos de l-lisina.